Overview
Hothouse Therapeutics raised £2.9 million in pre-seed funding to develop an AI-enabled plant bioengineering platform for drug discovery and manufacturing. Key investors include Synbioven, Start Codon, and Innovate UK.
Products
Loading...
Recent Deals
$3.625M
Investors: Synbioven, Start Codon, Innovate UK
Hothouse Therapeutics raised £2.9 million in pre-seed funding to develop an AI-enabled plant bioengineering platform for drug discovery and manufacturing. Key investors include Synbioven, Start Codon, and Innovate UK.
Investors: Synbioven, Start Codon, Wren Capital
Hothouse Therapeutics, a UK-based drug discovery platform, raised £2.9 million in pre-seed funding, led by investors including Synbioven, Start Codon, and Wren Capital. The company aims to enhance its operations and R&D efforts, utilizing AI to address challenges in drug development.